EuroMIT 2026 back in France, in Angers!
The EuroMIT 2026 International Congress on Mitochondrial Diseases will take place from 30 May to… Read More »EuroMIT 2026 back in France, in Angers!
Home >
MitoGether
TK2 deficiency: first treatment approved in the United States
Kygevvi®, the treatment developed Par UCB for thymidine kinase 2 deficiency (TK2d), was approved Par… Read More »TK2 deficiency: first treatment approved in the United States
The new AFM-Téléthon quarterly watch is out!
It’s not always easy to find medical and scientific publications on mitochondrial diseases. At AFM-Téléthon,… Read More »The new AFM-Téléthon quarterly watch is out!
A (very) large French cohort of patients under the microscope
The results of a large-scale study confirm the great diversity and heterogeneity of mitochondrial diseases… Read More »A (very) large French cohort of patients under the microscope
Encouraging results from sonlicromanol
A European clinical trial shows benefits of sonlicromanol on several symptoms of diseases associated with… Read More »Encouraging results from sonlicromanol
The new AFM-Téléthon quarterly watch is out!
It’s not always easy to find medical and scientific publications on mitochondrial diseases. At AFM-Téléthon,… Read More »The new AFM-Téléthon quarterly watch is out!